About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Dallas | 556 Studies

Clinical Trials Breast CancerDallas

Breast Cancer Clinical Trials in Dallas

Find 556 clinical trials for breast cancer near Dallas, Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Dallas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 361-380 of 556 trials

TerminatedA Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsThis is an open-label, multicenter, First-In-Human (FIH), Phase 1a/1b study of PY159 in subjects with locally advanced (unresectable) and/or metastatic solid tumors that are…NCT04682431·Los Angeles, California and 16 others Active not recruitingAbbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense BreastsThis randomized phase II trial studies how well abbreviated breast magnetic resonance imaging (MRI) and digital tomosynthesis mammography work in detecting cancer in women with…NCT02933489·Gilbert, Arizona and 67 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedStudy of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneOpen-label, Phase I-II, first-in-human (FIH) study for A166 monotherapy in HER2-expressing or amplified patients who progressed on or did not respond to available standard…NCT03602079·Sarasota, Florida and 9 others

Active not recruitingExemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticThis randomized phase III trial studies exemestane and entinostat to see how well they work compared to exemestane alone in treating patients with hormone receptor-positive breast…NCT02115282·Birmingham, Alabama and 652 others

CompletedA Study of PRT2527 in Participants With Advanced Solid TumorsThis is a Phase 1 dose-escalation and confirmation study of PRT2527, a Cyclin-dependent Kinase 9 (CDK9) inhibitor, in participants with advanced solid tumors.NCT05159518·Denver, Colorado and 7 others

Active not recruitingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersTTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase 2 dose of TTX-080 monotherapy…NCT04485013·Tucson, Arizona and 40 others

CompletedFirst-in-Human Dose Escalation Trial in Subjects With Advanced MalignanciesThis is a Phase 1, first-in-human, open-label, non-randomized, dose escalation, trial to explore the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical…NCT01971515·Birmingham, Alabama and 14 others

RecruitingConverting HR+ Breast Cancer Into an Individualized VaccineNewly diagnosed post-menopausal women with clinical stage II-III, HR+HER2- breast cancer are eligible to a randomized trial, concurrently open at five US academic institutions.NCT03804944·Los Angeles, California and 7 others

CompletedUsing Hyperpolarized [1-13C]Pyruvate to Detect CardiotoxicityThe anthracycline doxorubicin, first introduced in the 1960's, continues to be an effectively utilized antineoplastic drug.NCT03685175·Dallas, Texas

CompletedA Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast CancerThis is a study to compare the antitumor activity of ramucirumab (IMC-1121B) and eribulin together versus eribulin alone, in participants with locally recurrent or metastatic…NCT01427933·Birmingham, Alabama and 51 others

CompletedABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid TumorsThis is an open-label dose escalation study designed to evaluate the safety and pharmacokinetics of ABBV-085 and determine the recommended Phase 2 dose (as monotherapy or in…NCT02565758·Phoenix, Arizona and 19 others

CompletedE7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast CancerThe purpose of this study is to compare Overall Survival (OS), Progression Free Survival (PFS), objective tumor response rate, duration of response, and safety in patients treated…NCT00388726·Birmingham, Alabama and 136 others

RecruitingA Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in…NCT06312176·Chandler, Arizona and 258 others

Active not recruitingDS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unresectable and/or metastatic breast…NCT03529110·Los Angeles, California and 163 others

CompletedXeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast CancerThis single arm study stratified patients into two treatment cohorts based on HER2-neu overexpression/amplification.NCT00127933·Los Angeles, California and 37 others

CompletedA Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)This randomized, 3-arm, multicenter, phase III study will evaluate the efficacy and safety of trastuzumab emtansine (T-DM1) with pertuzumab or trastuzumab emtansine (T-DM1) with…NCT01120184·Little Rock, Arkansas and 256 others

Active not recruitingTH1902 in Patients With Advanced Solid TumorsOpen label first-in-human study of TH1902 in solid cancer, with 4 sequential parts: Part 1 (dose escalation): patients with recurrent advanced solid tumors (all comers) that have…NCT04706962·Detroit, Michigan and 5 others

RecruitingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)The Phase 2 monotherapy portion of this study is currently enrolling and will evaluate the efficacy and safety of PC14586 (INN rezatapopt) in participants with locally advanced or…NCT04585750·Irvine, California and 76 others

Active not recruitingThe IDEA Study (Individualized Decisions for Endocrine Therapy Alone)This study will collect rates of local/regional recurrence in select patients who do not receive radiation treatment after lumpectomy surgery.NCT02400190·Stanford, California and 12 others

TerminatedStudy of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsThis study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene…NCT04383210·Birmingham, Alabama and 41 others

PreviousPage 19 of 28Next

Other Conditions in Dallas

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma